BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7439279)

  • 1. Intralesional injection of BCG using the fibreoptic bronchoscope in the treatment of bronchogenic carcinoma.
    Millar JW; Hunter AM; Wightman AJ; Horne NW
    Eur J Respir Dis; 1980 Jun; 61(3):162-6. PubMed ID: 7439279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG immunotherapy of lung cancer.
    Holmes EC
    Jpn J Surg; 1980 Mar; 10(1):1-6. PubMed ID: 7373947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
    Warren SE; Crispen RG; Nika B
    Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolized BCG (Tice strain) treatment of bronchogenic carcinoma: phase I study.
    Cusumano CL; Jernigan JA; Waldman RH
    J Natl Cancer Inst; 1975 Aug; 55(2):275-9. PubMed ID: 169370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional BCG immunotherapy of pulmonary tumors.
    Holmes EC; Ramming KP; Bein ME; Coulson WF; Callery CD
    J Thorac Cardiovasc Surg; 1979 Mar; 77(3):362-8. PubMed ID: 762979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional BCG injection of pulmonary neoplasms: radiographic findings.
    Fon GT; Bein ME; Holmes EC; Huberman RP
    AJR Am J Roentgenol; 1981 Aug; 137(2):269-75. PubMed ID: 6789633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy with BCG and mycobacterial fractions and its use in bronchogenic carcinoma (author's transl)].
    Brehmer W; Huckauf H; Ribi E
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():358-65. PubMed ID: 461310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma.
    Vattanathum A; Wongsa A; Tantamacharik D; Palwatwichai A; Chantarotorn S; Chanthadisai N
    J Med Assoc Thai; 1999 Aug; 82(8):765-9. PubMed ID: 10511783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year results of a controlled study of BCG immunotherapy after surgical resection in bronchogenic carcinoma.
    Millar JW; Roscoe P; Pearce SJ; Ludgate S; Horne NW
    Thorax; 1982 Jan; 37(1):57-60. PubMed ID: 7041323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG immunostimulation in primary pulmonary cancer (a clinical, immunological and radiological study).
    Dénes L; Büttner K; Galambos G; Krasznai G
    Dev Biol Stand; 1986; 58 ( Pt A)():425-32. PubMed ID: 3297874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
    Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term results of intratumor BCG injection for rectal carcinoma].
    Zhu HM
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):40-2. PubMed ID: 2364870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulomatous hepatitis in a healthy adult following BCG injection into a plantar wart.
    D'Alessandria RM; Khakoo RA
    Am J Gastroenterol; 1977 Oct; 68(4):392-5. PubMed ID: 605897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoimmunotherapy of small cell bronchogenic carcinoma.
    Holoye PY; Samuels ML; Smith T; Sinkovics JG
    Cancer; 1978 Jul; 42(1):34-40. PubMed ID: 208755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
    Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of systemic administration of BCG cell walls on bronchogenic carcinoma in hamsters.
    Zwilling BS; Springer ST; Kaufman DG
    J Natl Cancer Inst; 1977 May; 58(5):1473-7. PubMed ID: 323508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?
    Lamm DL
    Cancer Surv; 1998; 31():99-108. PubMed ID: 15281319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with flexible fibreoptic bronchoscopy.
    Jayasundera C
    Ceylon Med J; 1996 Dec; 41(4):131-4. PubMed ID: 9141755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.